BDBM479524 6-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-3- amino-N-((3-fluoropyridin-2-yl) methyl)-5-(oxazol-2-yl)pyrazine-2- carboxamide::US10898481, Compound 100::US11571420, Compound 100

SMILES Nc1nc(-c2ncco2)c(nc1C(=O)NCc1ncccc1F)-c1ccc2ncnn2c1

InChI Key InChIKey=XBIYCWPAQSHBMY-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 479524   

TargetAdenosine receptor A2a(Human)
TBA

US Patent
LigandPNGBDBM479524(6-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-3- amino-N-...)
Affinity DataIC50: 8.40nMAssay Description:The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
TBA

US Patent
LigandPNGBDBM479524(6-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-3- amino-N-...)
Affinity DataIC50: 8.40nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
TBA

US Patent
LigandPNGBDBM479524(6-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-3- amino-N-...)
Affinity DataIC50: 685nMAssay Description:The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
TBA

US Patent
LigandPNGBDBM479524(6-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-3- amino-N-...)
Affinity DataIC50: 685nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent